Plant ID: NPO10671
Plant Latin Name: Zephyranthes Candida
Taxonomy Genus: Zephyranthes
Taxonomy Family: Amaryllidaceae
NCBI TaxonomyDB:
82257
Plant-of-the-World-Online:
n.a.
Ingredient ID: NPC89972
Ingredient ID: NPC78359
Ingredient ID: NPC71124
Ingredient ID: NPC56540
Ingredient ID: NPC5374
Ingredient ID: NPC486691
Ingredient ID: NPC486690
Ingredient ID: NPC486689
Ingredient ID: NPC486688
Ingredient ID: NPC486687
Ingredient ID: NPC486686
Ingredient ID: NPC486685
Ingredient ID: NPC486684
Ingredient ID: NPC486683
Ingredient ID: NPC486682
Ingredient ID: NPC486681
Ingredient ID: NPC486680
Ingredient ID: NPC486679
Ingredient ID: NPC486678
Ingredient ID: NPC479632
Ingredient ID: NPC479631
Ingredient ID: NPC479630
Ingredient ID: NPC475919
Ingredient ID: NPC470739
Ingredient ID: NPC470738
Ingredient ID: NPC321781
Ingredient ID: NPC318745
Ingredient ID: NPC316602
Ingredient ID: NPC302727
Ingredient ID: NPC299459
Ingredient ID: NPC289743
Ingredient ID: NPC285556
Ingredient ID: NPC268077
Ingredient ID: NPC266176
Ingredient ID: NPC254957
Ingredient ID: NPC252960
Ingredient ID: NPC251884
Ingredient ID: NPC24954
Ingredient ID: NPC247300
Ingredient ID: NPC234197
Ingredient ID: NPC229023
Ingredient ID: NPC218614
Ingredient ID: NPC207971
Ingredient ID: NPC190332
Ingredient ID: NPC18402
Ingredient ID: NPC182840
Ingredient ID: NPC181653
Ingredient ID: NPC180306
Ingredient ID: NPC153231
Ingredient ID: NPC148398
Ingredient ID: NPC143428
Ingredient ID: NPC141440
Ingredient ID: NPC118246
Ingredient ID: NPC110374
Ingredient ID: NPC105264
Ingredient ID: NPC102760
Clinical trials associated with plant from natural product (NP) & plant level:
Clinical trials type | Number of clinical trials | |
---|---|---|
NP level | 32 | |
NCT ID | Title | Condition | Form in clinical use | Associated by plant or compound |
---|---|---|---|---|
NCT01677754 | A Study of RO4602522 in Participants With Moderate Severity Alzheimer Disease on Background Alzheimer Disease Therapy | Alzheimer disease | Galantamine (NPC78359) | NP level |
NCT00750529 | Alzheimer and Sleep | Alzheimer disease | Galantamine (NPC78359) | NP level |
NCT01669538 | Effect of Galantamine on Short-term Abstinence | nicotine dependence | Galantamine (NPC78359) | NP level |
NCT00463879 | Galantamine for Cognitive Deficits in Schizophrenia | schizophrenia | Galantamine (NPC78359) | NP level |
NCT01372306 | Galantamine Bioequivalence Study of Dr. Reddy's Under Fed Condition | Fish-eye disease | Galantamine (NPC78359) | NP level |
NCT03384784 | Effect of Galantamine on Inflammation and Cognition | HIV infection | Galantamine (NPC78359) | NP level |
NCT01039194 | Drug-Drug Interaction to Study the Effect of BMS-708163 on Pharmacokinetics (PK) of Galantamine Extended Release (ER) | Alzheimer disease | Galantamine (NPC78359) | NP level |
NCT01417429 | Galantamine Effects on Nicotine Responses in Smokers | nicotine dependence | Galantamine (NPC78359) | NP level |
NCT00509067 | Use of Galantamine and CDP-choline (Citicoline) to Treat Adults With Schizophrenia | schizophrenia | Galantamine (NPC78359) | NP level |
NCT02872857 | Subarachnoid Hemorrhage Recovery And Galantamine | subarachnoid hemorrhage | Galantamine (NPC78359) | NP level |
NCT00814801 | An Efficacy and Safety Study of Galantamine for the Treatment of Patients With Alzheimer's Disease | Alzheimer disease | Galantamine (NPC78359) | NP level |
NCT00035191 | A Placebo-controlled Trial to Evaluate the Safety and Efficacy of Galantamine in the Treatment of Vascular Dementia | vascular dementia | Galantamine (NPC78359) | NP level |
NCT00969696 | Galantamine Effects on Cognitive Function in Marijuana Users | memory impairment | Galantamine (NPC78359) | NP level |
NCT02234752 | Galantamine and Memantine Combination for Cognitive Impairments in Schizophrenia | schizoaffective disorder;schizophrenia | Galantamine (NPC78359) | NP level |
NCT00809835 | Galantamine to Enhance Cognitive Behavioral Therapy for Cocaine Abuse | cocaine dependence | Galantamine (NPC78359) | NP level |
NCT01548638 | Effect of Galantamine on Smoking Abstinence | nicotine dependence | Galantamine (NPC78359) | NP level |
NCT00301574 | An Efficacy and Safety Study of Galantamine for the Treatment of Patients With Alzheimer's Disease. | Alzheimer disease | Galantamine (NPC78359) | NP level |
NCT00679627 | A Study of Galantamine Used to Treat Patients With Mild to Moderate Alzheimer's Disease | Alzheimer disease | Galantamine (NPC78359) | NP level |
NCT00252603 | Galantamine Versus Placebo in Childhood Autism | autism | Galantamine (NPC78359) | NP level |
NCT02248636 | Cholinesterase Inhibitor Discontinuation | Dementia | Galantamine (NPC78359) | NP level |
NCT02374567 | Pharmacovigilance in Gerontopsychiatric Patients | anxiety;depressive disorder;schizophrenia;Dementia | Galantamine (NPC78359) | NP level |
NCT00000172 | Evaluation of Galantamine in the Treatment of Alzheimer's Disease | Alzheimer disease | Galantamine (NPC78359) | NP level |
NCT00645190 | A Randomized, Double-blind, Flexible Dose, Multicenter Study to Evaluate the Effectiveness and Safety of Galantamine IR in Mild to Moderate Alzheimer's Disease | Alzheimer disease | Galantamine (NPC78359) | NP level |
NCT03124355 | Vagal Stimulation in POTS | orthostatic hypotension | Galantamine (NPC78359) | NP level |
NCT00309725 | A Cardiac Safety Study of Galantamine in the Treatment of Alzheimer's Disease. | Alzheimer disease | Galantamine (NPC78359) | NP level |
NCT00304629 | Long-term Safety and Efficacy of Galantamine in Alzheimer's Disease | Alzheimer disease | Galantamine (NPC78359) | NP level |
NCT01100775 | Effects of Galantamine on Cognition | schizophrenia | Galantamine (NPC78359) | NP level |
NCT00814658 | The Use of Galantamine (Reminyl ER) in Patients With MIXed Dementia: Effects on Cognition and Quality of Life | Dementia | Galantamine (NPC78359) | NP level |
NCT01012167 | Oxytocin or Galantamine Versus Placebo for the Treatment of Negative Symptoms and Cognitive Impairments in Schizophrenia | schizophrenia | Galantamine (NPC78359) | NP level |
NCT00230997 | Safety and Efficacy of Galantamine in Patients With Dementia With Lewy Bodies | Lewy body dementia | Galantamine (NPC78359) | NP level |
NCT02365285 | Racial Differences in Vagal Control of Glucose Homeostasis | obesity | Galantamine (NPC78359) | NP level |
NCT00082602 | Safety and Tolerability Study of Extended Release (ER) Galantamine in Alzheimer's Disease | Alzheimer disease | Galantamine (NPC78359) | NP level |
How do we define the Plant-Targeted Human Disease Association?
Associated human diseases of an individual plant are summurized based on FOUR types of association evidence, these include:
❶ Association by Therapeutic Target: Bioactive protein targets of the plant were defined in "Molecular Targets" section, target-disease associations collected from TTD database were subsequently used to build the associations between the plant and its targeted human diseases.
❷ Association by Disease Gene Reversion: Plant and a specific disease will be associated when >= 1 plant target gene overlaped with disease's DEGs.
❸ Association by Clinical Trials of Plant: Plant and a specific disease will be associated when >= 1 clinical trial (the plant is the intervetion) can be matched in ClinicalTrials.gov database.
❹ Association by Clinical Trials of Plant Ingredients: Plant and a specific disease will be associated when >= 1 clinical trial (the plant ingredient is the intervetion) can be matched in ClinicalTrials.gov database.
Associated Disease of the Plant |
Association Type & Detailed Evidence |
---|---|
SchizophreniaDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6A20 |
NCT01012167,NCT01100775,NCT00463879,NCT02234752,NCT02374567,NCT00509067
|
DementiaDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6D80-6D8Z |
ACHE
NCT00230997,NCT02248636,NCT00814658,NCT02374567 |
Nicotine use disorderDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6C4A |
NCT01548638,NCT01669538,NCT01417429
|
Mild neurocognitive disorderDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6D71 |
BCHE,ACHE
|
Pain, unspecifiedDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: MG3Z |
ACHE,BCHE
|
PheochromocytomaDisease Category: X.Extension CodesDisease ICD-11 Code: XH3854 |
ACHE,BCHE
|
Other specified malignant neoplasms of kidney, except renal pelvisDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C90.Y |
ACHE,BCHE
|
Adenocarcinoma of pancreasDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C10.0 |
ACHE,BCHE
|
Germ cell tumour of testisDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C80.2 |
ACHE,BCHE
|
Alzheimer diseaseDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8A20 |
BCHE,ACHE
NCT00645190,NCT00301574,NCT00304629,NCT00814801,NCT01677754,NCT00750529,NCT00309725,NCT00679627,NCT00082602,NCT00000172,NCT01039194 |
Unspecific substance harmful effectDisease Category: 22.Injury, poisoning or certain other consequences of external causesDisease ICD-11 Code: NE6Z |
ACHE
|
GlaucomaDisease Category: 09.Diseases of the visual systemDisease ICD-11 Code: 9C61 |
ACHE
|
PediculosisDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1G00 |
ACHE
|
Parasitic worm infestationDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1F90 |
ACHE
|
ParkinsonismDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8A00 |
ACHE
|
Eexposure to noxious substances harmful effectDisease Category: 22.Injury, poisoning or certain other consequences of external causesDisease ICD-11 Code: NE61 |
BCHE
|
Substance abuseDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6C40 |
ACHE
|
Tonus and reflex abnormalityDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: MB47 |
BCHE
|
Oesophageal/gastroduodenal disorderDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DD90 |
ACHE
|
Myasthenia gravisDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8C6Y |
ACHE
|
Age-associated cognitive declineDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: MB21.0 |
NCT00969696
|
ObesityDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5B80-5B81 |
NCT02365285
|
HypoalphalipoproteinaemiaDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5C81.0 |
NCT01372306
|
Cocaine use disorderDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6C45 |
NCT00809835
|
Schizoaffective disorderDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6A21 |
NCT02234752
|
Subarachnoid haemorrhageDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8B01 |
NCT02872857
|
Autism spectrum disorderDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6A02 |
NCT00252603
|
Dementia due to cerebrovascular diseaseDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6D81 |
NCT00035191
|
Orthostatic hypotensionDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BA21 |
NCT03124355
|
AnxietyDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: MB24.3 |
NCT02374567
|
Human immunodeficiency virus disease without mention of associated disease or condition, clinical stage unspecifiedDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1C62.Z |
NCT03384784
|
Depressive disorders, unspecifiedDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6A7Z |
NCT02374567
|
Zika virus diseaseDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1D48 |
ACHE
|
Malignant neoplasm metastasis in lymph nodes of head, face or neckDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2D60.0 |
BCHE
|
Diffuse large B-cell lymphomasDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A81 |
ACHE
|
West Nile virus infectionDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1D46 |
ACHE
|
Mesothelioma of pleuraDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C26.0 |
BCHE
|
Superficial ovarian endometriosisDisease Category: 16.Diseases of the genitourinary systemDisease ICD-11 Code: GA10.B4 |
ACHE
|
Malignant neoplasms of oesophagusDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B70 |
ACHE
|
Cytomegaloviral diseaseDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1D82 |
ACHE
|
Systemic lupus erythematosusDisease Category: 04.Diseases of the immune systemDisease ICD-11 Code: 4A40.0 |
ACHE
|
Adenocarcinoma of bronchus or lungDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C25.0 |
ACHE
|
Malignant neoplasms of thymusDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C27 |
ACHE
|
Ebola virus diseaseDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1D60.01 |
ACHE
|
Malignant neoplasms of adrenal glandDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2D11 |
BCHE
|